Exposure to tetrachloroethylene might triple the risk of significant liver fibrosis -- an excessive amount of liver scarring ...
MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting data on Vanoglipel (DA-1241), a ...
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing breakthrough therapies for metabolic, dermatologic, and inflammatory diseases, today announced the initiation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback